Patient Reported Outcomes With WaveLight Plus LASIK
Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18-39
SponsorMann Eye Institute
About this trial
This study is a single-site, single-arm, prospective, observational study of subject satisfaction, quality of vision, and quality of life after bilateral LASIK surgery. Subjects will be assessed up to 3 months post-operatively. Clinical evaluations will include refractive outcomes, visual acuity, and administration of the adapted PROWL and the Quality-of-Life Impact of Refractive Correction (QIRC) Questionnaire.
Eligibility criteria
Qualifiers
Between the ages of 18 and 39
Meet the standard care requirements for LASIK
Spherical equivalent (SE) more than -1.00D and up to -9.00 diopters
Myopia ≤ -8.00 sphere (in minus cylinder format) and up to -3.00D astigmatism
Disqualifiers
Subjects with any prior ocular surgery
Subjects with topographic evidence of keratoconus, or ectasia
Subjects with autoimmune diseases
Subjects who are pregnant or nursing
Trial design
Treatments tested in this trial
- WaveLigh Plus LASIK
Treatment groups
No treatment groups listed
Sponsors and collaborators
Mann Eye Institute
Lead sponsor
Sengi
Collaborator
Source ClinicalTrials.gov